Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AAK1 | Q2M2I8 | 4/20 | 0.44 |
| ▸ | GSK3B | P49841 | 13/20 | 0.38 |
| ▸ | MAPT | P10636 | 12/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | GSK3A | P49840 | 1/20 | 0.35 |
| ▸ | ACACB | O00763 | 1/20 | 0.33 |
| ▸ | ACACA | Q13085 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30953417 | 0.89 | AAK1 (0.44) | AAK1GSK3BMAPTGSK3A | |
| SCHEMBL30953416 | 0.87 | AAK1 (0.42) | AAK1GSK3BMAPTMAPK1GSK3A | |
| SCHEMBL30953508 | 0.87 | AAK1 (0.42) | AAK1GSK3BMAPTMAPK1GSK3A | |
| SCHEMBL30953319 | 0.86 | AAK1 (0.55) | AAK1GSK3BMAPTMAPK1 | |
| SCHEMBL30953311 | 0.85 | AAK1 (0.44) | AAK1GSK3BMAPTMAPK1 | |
| SCHEMBL30953439 | 0.85 | AAK1 (0.44) | AAK1MAPK1MEN1KMT2A | |
| SCHEMBL30953210 | 0.85 | AAK1 (0.46) | AAK1MAPK1MEN1KMT2A | |
| SCHEMBL30953388 | 0.84 | AAK1 (0.46) | AAK1GSK3BMAPTMAPK1 | |
| SCHEMBL30953227 | 0.81 | AAK1 (0.41) | AAK1MAPK1 | |
| SCHEMBL30953293 | 0.80 | AAK1 (0.41) | AAK1MAPK1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4630115-A1 | THERAPEUTIC COMPOUNDS | Sanofi (FR) | 2025-10-15 | — | — | EP | disclosed |
| WO-2024121427-A1 | THERAPEUTIC COMPOUNDS | SANOFI (FR) | 2024-06-13 | — | — | WO | disclosed |